1. Home
  2. EMF vs STXS Comparison

EMF vs STXS Comparison

Compare EMF & STXS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • EMF
  • STXS
  • Stock Information
  • Founded
  • EMF 1987
  • STXS 1990
  • Country
  • EMF United States
  • STXS United States
  • Employees
  • EMF N/A
  • STXS N/A
  • Industry
  • EMF Finance/Investors Services
  • STXS Biotechnology: Electromedical & Electrotherapeutic Apparatus
  • Sector
  • EMF Finance
  • STXS Health Care
  • Exchange
  • EMF Nasdaq
  • STXS Nasdaq
  • Market Cap
  • EMF 219.3M
  • STXS 151.3M
  • IPO Year
  • EMF N/A
  • STXS 2004
  • Fundamental
  • Price
  • EMF $14.89
  • STXS $2.25
  • Analyst Decision
  • EMF
  • STXS
  • Analyst Count
  • EMF 0
  • STXS 0
  • Target Price
  • EMF N/A
  • STXS N/A
  • AVG Volume (30 Days)
  • EMF 29.3K
  • STXS 292.4K
  • Earning Date
  • EMF 01-01-0001
  • STXS 08-11-2025
  • Dividend Yield
  • EMF 6.16%
  • STXS N/A
  • EPS Growth
  • EMF N/A
  • STXS N/A
  • EPS
  • EMF N/A
  • STXS N/A
  • Revenue
  • EMF N/A
  • STXS $27,510,000.00
  • Revenue This Year
  • EMF N/A
  • STXS $25.90
  • Revenue Next Year
  • EMF N/A
  • STXS $60.57
  • P/E Ratio
  • EMF N/A
  • STXS N/A
  • Revenue Growth
  • EMF N/A
  • STXS 1.50
  • 52 Week Low
  • EMF $10.58
  • STXS $1.54
  • 52 Week High
  • EMF $12.67
  • STXS $2.72
  • Technical
  • Relative Strength Index (RSI)
  • EMF 72.86
  • STXS 55.31
  • Support Level
  • EMF $14.78
  • STXS $2.12
  • Resistance Level
  • EMF $14.99
  • STXS $2.36
  • Average True Range (ATR)
  • EMF 0.18
  • STXS 0.10
  • MACD
  • EMF 0.02
  • STXS 0.00
  • Stochastic Oscillator
  • EMF 91.15
  • STXS 75.76

About EMF Templeton Emerging Markets Fund

Templeton Emerging Markets Fund is a closed-end management investment company. It seeks long-term capital appreciation by investing, under normal market conditions, at least 80% of its net assets in emerging country equity securities. It invests in various sectors such as Pharmaceuticals, Beverages, Broadline Retail, Metals &Mining, Banks, Food Products, Semiconductors & Semiconductor Equipment, insurance, Entertainment, and others.

About STXS Stereotaxis Inc.

Stereotaxis Inc is engaged in robotic technologies designed to enhance the treatment of arrhythmias and perform endovascular procedures. The company's mission is the discovery, development, and delivery of robotic systems, instruments, and information solutions for the interventional laboratory. These innovations help physicians provide patient care with robotic precision and safety, improved lab efficiency and productivity, and enhanced integration of procedural information. The company's revenue generation is derived from the streams of Systems; Disposables, Royalty; and Sublease, of which a majority of revenue is generated from the Disposables, service, and accessories stream.

Share on Social Networks: